The effect of narrowband UV-B treatment for psoriasis on vitamin D status during wintertime in Ireland

Archives of Dermatology

Volumn 146, Issue 8, 2010, Pages 836-842

  Ryan, Caitriona ^a,b   Moran, Benvon ^a   McKenna, Malachi J ^a   Murray, Barbara F ^a   Brady, Jennifer ^a   Collins, Paul ^a   Rogers, Sarah ^a   Kirby, Brian ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM ION; CYCLOSPORIN; ETRETIN; FUMARIC ACID ETHYL ESTER; METHOTREXATE; PARATHYROID HORMONE; PHOSPHATE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXPOSURE; FEMALE; HUMAN; IRELAND; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOTOTHERAPY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WINTER; ANALOGS AND DERIVATIVES; BLOOD; FOLLOW UP; MIDDLE AGED; PROCEDURES; RADIATION RESPONSE; REGRESSION ANALYSIS; SEASON; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; YOUNG ADULT;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; IRELAND; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; REGRESSION ANALYSIS; SEASONS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 77955869458     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.195     Document Type: Article

References (34)

1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263-271.
2. Ibbotson SH, Bilsland D, Cox NH, et al; British Association of Dermatologists. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop report. Br J Dermatol. 2004;151(2):283-297.
3. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76(5):359-362.
4. Guilhou JJ, Colette C, Monpoint S, Lancrenon E, Guillot B, Monnier L. Vitamin D metabolism in psoriasis before and after phototherapy. Acta Derm Venereol. 1990; 70(4):351-354.
5. Osmancevic A, Landin-Wilhelmsen K, Larko O, et al. UVB therapy increases 25 (OH) vitamin D syntheses in postmenopausal women with psoriasis. Photodermatol Photoimmunol Photomed. 2007;23(5):172-178. (Pubitemid 47354708)
6. Osmancevic A, Landin-Wilhelmsen K, Larko O, Wennberg AM, Krogstad AL. Vitamin D production in psoriasis patients increases less with narrowband than with broadband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed. 2009;25(3):119-123.
7. Czarnecki D. Narrowband ultraviolet B therapy is an effective means of raising serum vitamin D levels. Clin Exp Dermatol. 2008;33(2):202. (Pubitemid 351197203)
8. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25- hydroxycholocalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204-210.
9. Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol. 2007;16(7):618-625.
10. Lehmann B, Genehr T, Knuschke P, Pietzsch J, Meurer M. UVB-induced conversion of 7-dehydrocholesterol to 1 alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol. 2001;117(5):1179-1185.
11. McKenna MJ. Differences of vitamin D status between countries in young adults and the elderly. Am J Med. 1992;93(1):69-77.
12. Armas LAG, Dowell S, Akhter M, et al. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin colour. J Am Acad Dermatol. 2007;57(4):588-593.
13. Bikle D, Adams J, Christakos S. Vitamin D: production, metabolism, mechanism of action, and clinical requirements. In: Rosen C, ed. Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington, DC: American Society for Bone and Mineral Research; 2008:141-149.
14. Singh S, Aiba S, Manome H, Tagami H. The effects of dexamethasone, cyclosporine, and vitamin D3 on the activation of dendritic cells stimulated by haptens. Arch Dermatol Res. 1999;291(10):548-554.
15. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1 alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor- dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A. 2001;98(12):6800-6805.
16. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem. 2003;88(2):227-233. (Pubitemid 36119891)
17. Griffin MD, Dong X, Kumar R. Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation. Arch Biochem Biophys. 2007;460(2):218-226.
18. Reichrath J, Rappl G. Ultraviolet light (UV)-induced immunosuppression: is vitamin D the missing link? J Cell Biochem. 2003;89(1):6-8.
19. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 in human skin. J Clin Endocrinol Metab. 1988; 67(2):373-378.
20. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713-716.
21. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
22. Markham T, Rogers S, Collins P. Narrowband UV-B (TL-O1) phototherapy vs oral 8-methoxypsoralen psoralen UVA for treatment of chronic plaque psoriasis. Arch Dermatol. 2003;139(3):325-328.
23. British National Formulary Web site. http://bnf.org/bnf/bnf/59/5760.htm. Accessed October 26, 2009.
24. Morimoto S, Yoshikawa K. Psoriasis and vitamin D3: a review of our experience. Arch Dermatol. 1989;125(2):231-234.
25. Staberg B, Oxholm A, Klemp P, Christiansen C. Abnormal vitamin D metabolism in patients with psoriasis. Acta Derm Venereol. 1987;67(1):65-68.
26. Dawe RS. A quantitative review of studies comparing the efficacy of narrowband and broad-band ultraviolet B for psoriasis. Br J Dermatol. 2003;149(3): 669-672.
27. McKenna MJ, Freaney R, Meade A, Muldowney FP. Hypovitaminosis D and elevated serum alkaline phosphatase in elderly Irish people. Am J Clin Nutr. 1985; 41(1):101-109.
28. Hill TR, McCarthy D, Jakobsen J, Lamberg-Allardt C, Kiely M, Cashman KD. Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women. Int J Vitam Nutr Res. 2007;77(5):320-325.
29. Moan J, Lagunova Z, Lindberg FA, Porojnicu AC. Seasonal variation of 1,25- dihydroxyvitamin D and its association with body mass index and age. J Steroid Biochem Mol Biol. 2009;113(3-5):217-221.
30. Holick MF. MrOs is D-ficient. J Clin Endocrinol Metab. 2009;94(4):1092-1093.
31. McKenna MJ, Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int. 1998;8(suppl 2):S3-S6.
32. McKenna MJ, Freaney R, Byrne P, et al. Safety and efficacy of increasing wintertime vitamin D and calcium intake by milk fortification. QJM. 1995;88(12): 895-898.
33. Cashman KD, Hill TR, Lucey AJ, et al. Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr. 2008;88(6):1535-1542.
34. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009;94(4):1244-1250.